Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Herhaus · SciRah

Researcher profile · Semantic Scholar

P. Herhaus

Share profile

P. Herhaus — researcher profile on SciRah

h-index: 14
Works: 48
Citations: 945

Most-cited papers

First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers
T. Vag, Carlos Gerngross, P. Herhaus, M. Eiber +6 more
2016Journal of Nuclear Medicine136 citations Open access
Semantic Scholar
CXCR4-directed theranostics in oncology and inflammation
M. Kircher, P. Herhaus, M. Schottelius, A. Buck +4 more
2018Annals of Nuclear Medicine114 citations Open access
Semantic Scholar
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of
M. Dreyling, J. Doorduijn, E. Giné, M. Jerkeman +34 more
2024The Lancet96 citations Open access
Semantic Scholar
Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics
Stefan Habringer, C. Lapa, P. Herhaus, M. Schottelius +16 more
2018Theranostics94 citations Open access
Semantic Scholar
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial
P. Bröckelmann, I. Bühnen, J. Meissner, Karolin Trautmann-Grill +14 more
2022Journal of Clinical Oncology87 citations Open access
Semantic Scholar
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
P. Herhaus, Stefan Habringer, K. Philipp-Abbrederis, T. Vag +18 more
2016Haematologica64 citations Open access
Semantic Scholar
Side Effects of CXC-Chemokine Receptor 4–Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation
Sabine Maurer, P. Herhaus, Romina Lippenmeyer, H. Hänscheid +9 more
2019Journal of Nuclear Medicine56 citations Open access
Semantic Scholar
CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma
P. Herhaus, Jana Lipková, F. Lammer, Igor Yakushev +15 more
2020Journal of Nuclear Medicine42 citations Open access
Semantic Scholar
PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma
T. Vag, K. Steiger, A. Rossmann, U. Keller +6 more
2018EJNMMI Research39 citations Open access
Semantic Scholar
Bacteria and Bacteriophage Consortia are Associated with Protective Intestinal Metabolites in Patients Receiving Stem Cell Transplantation
Erik Thiele Orberg, E. Meedt, A. Hiergeist, Jinling Xue +33 more
2024Nature Cancer33 citations Open access
Semantic Scholar
Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities
P. Herhaus, Stefan Habringer, T. Vag, K. Steiger +6 more
2017EJNMMI Research28 citations Open access
Semantic Scholar
Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis
S. Kraus, P. Klassen, M. Kircher, A. Dierks +16 more
2022Theranostics23 citations Open access
Semantic Scholar
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients
Richard Lewis, Stefan Habringer, M. Kircher, Maike Hefter +10 more
2021EJNMMI Research23 citations Open access
Semantic Scholar
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
H. Bonig, Mareike Verbeek, P. Herhaus, K. Braitsch +20 more
2023Journal of Translational Medicine22 citations Open access
Semantic Scholar
Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group
A. Burchert, S. Saussele, Christian Michel, S. Metzelder +30 more
2022Blood13 citations Open access
Semantic Scholar
CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma
P. Herhaus, Jana Lipková, F. Lammer, J. Slotta-Huspenina +15 more
2019Blood9 citations Open access
Semantic Scholar
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
K. Braitsch, Alix Schwarz, Katrin Koch, Mara Hubbuch +6 more
2022Annals of Hematology8 citations Open access
Semantic Scholar
Fulminant Adenoviral-Induced Hepatitis in Immunosuppressed Patients
J. Kager, J. Schneider, Sebastian Rasch, P. Herhaus +7 more
2022Viruses8 citations Open access
Semantic Scholar
First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers
T. Vag, Carlos Gerngross, P. Herhaus, M. Eiber +7 more
20168 citations
Semantic Scholar
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network.
M. Dreyling, Jeanette Doorduijn, E. Giné, M. Jerkeman +34 more
2026The Lancet6 citations Open access
Semantic Scholar
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
A. Burchert, F. Nicolini, P. le Coutre, S. Saussele +49 more
2026Leukemia6 citations Open access
Semantic Scholar
Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
V. Dill, K. Kirmes, Jia-Ying Han, M. Klug +15 more
2024Platelets5 citations Open access
Semantic Scholar
Letermovir Prophylaxis for CMV Reactivation in Allogeneic Stem Cell Recipients: A Retrospective Single Center Analysis
Katrin Koch, Lena Osswald, Isabella V. Miller, K. Braitsch +4 more
2022Anticancer Research5 citations Open access
Semantic Scholar
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation
Theresa Landspersky, Merle Stein, M. Saçma, J. Geuder +18 more
2024Blood Advances4 citations Open access
Semantic Scholar
Rapid molecular response kinetics to anti-PD-1–based first-line treatment of Hodgkin lymphoma in the GHSG NIVAHL trial
J. Heger, J. Mattlener, P. Herhaus, J. Meissner +12 more
2026Blood Advances3 citations Open access
Semantic Scholar
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf A. Werner, Alexander Haug, C. Buske, S. Heidegger +14 more
2023NuclearMedicine3 citations Open access
Semantic Scholar
Peptide-Receptor Radiotherapy with CXCR4-Targeting Pentixather Reduces Leukemia Burden in Acute Leukemia PDX and Patients
Stefan Habringer, P. Herhaus, M. Schottelius, C. Lapa +10 more
20163 citations
Semantic Scholar
CIRCULATING TUMOR DNA SEQUENCING REVEALS RAPID RESPONSE KINETICS TO ANTI‐PD1 BASED FIRST‐LINE TREATMENT OF HODGKIN LYMPHOMA: MOLECULAR INSIGHTS FROM THE GHSG NIVAHL TRIAL
J. Heger, J. Mattlener, P. Herhaus, J. Meissner +11 more
2025Hematological Oncology2 citations
Semantic Scholar
Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial.
A. S. Robertz, I. Bühnen, J. Meissner, K. Trautmann-Grill +15 more
2026Blood1 citations
Semantic Scholar
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response
K. Braitsch, S. Jeske, Jacob Stroh, Maike Hefter +13 more
2024Vaccines1 citations Open access
Semantic Scholar
Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial
P. Bröckelmann, I. Bühnen, P. Herhaus, J. Meissner +7 more
2023Blood1 citations Open access
Semantic Scholar
Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial
P. Bröckelmann, I. Bühnen, J. Meissner, K. Trautmann-Grill +14 more
2022Blood1 citations Open access
Semantic Scholar
Longitudinal Analysis of Gut Bacteriome, Mycobiome, Virome and Metabolome in Allogeneic Stem Cell Transplantation Reveals Susceptibility for Acute Graft-Versus-Host Disease
Erik Thiele-Orberg, E. Meedt, A. Hiergeist, Jinling Xue +16 more
2021Blood1 citations Open access
Semantic Scholar
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
M. Ladetto, K. Gutmair, R. Tavarozzi, Alexandra Pawlikowski +36 more
2026Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Quality of life with nivolumab and AVD first‐line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial
C. Jaworek, I. Bühnen, P. Herhaus, J. Meissner +9 more
2026HemaSphere0 citations Open access
Semantic Scholar
Discontinuing Ciprofloxacin Prophylaxis in Allogeneic Stem Cell Transplantation Does Not Result in Inferior Outcomes.
K. Braitsch, Vanessa Möbius, Katrin Koch, K. Rothe +9 more
2026Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
Enhancing the sequential flamsa-treosulfan conditioning regimen with venetoclax – first results from the multicenter flamsaclax Phase I/II trial
Felicitas Schulz, U. Holtick, Mareike Verbeek, Edgar Jost +11 more
2025Blood0 citations
Semantic Scholar
The role of microbial metabolites in fecal microbiota transplantation in patients with acute gvhd of the gut
Alix Schwarz, Simon Holzinger, P. Herhaus, Mareike Verbeek +18 more
2025Blood0 citations
Semantic Scholar
Recovery of the Intestinal Microbiome in Patients at Day +100 after Allogeneic Stem Cell Transplantation Is Defined By Microbial Metabolite Profiles and Linked to Long-Term Outcomes
Alix Schwarz, Tina Eismann, Ting-Ting Zheng, S. Goeldel +17 more
2024Blood0 citations
Semantic Scholar
Omitting Ciprofloxacin Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Result in Inferior Outcomes
K. Braitsch, Vanessa Nehrbaß, Katharina Nickel, Maike Hefter +7 more
2024Blood0 citations
Semantic Scholar
Loss of Microbiota-Derived Metabolites Is Associated with Mucosal-Barrier-Injury Bloodstream Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Sophia Göldel, Ting-Ting Zheng, Tina Eismann, Melanie Tiefgraber +20 more
2024Blood0 citations
Semantic Scholar
Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG Nivahl Trial
P. Bröckelmann, I. Bühnen, P. Herhaus, J. Meissner +7 more
2023Blood0 citations Open access
Semantic Scholar
Real-World Data Suggest Effectiveness of Allogeneic Mesenchymal Stromal (MSC-FFM) Cells in Ruxolitinib-Refractory Acute Graft-Versus-Host Disease
P. Bader, Mareike Verbeek, P. Herhaus, Lavinia Pachzelt +18 more
2023Blood0 citations Open access
Semantic Scholar
3111 – IMPROVING BONE MARROW TRANSPLANTATION OUTCOMES THROUGH NICHE REGENERATION STRATEGIES
Theresa Landspersky, M. Saçma, J. Geuder, K. Braitsch +9 more
2023Experimental Hematology0 citations
Semantic Scholar
Bacterial and Bacteriophage Consortia Are Associated with Protective Intestinal Immuno-Modulatory Metabolites in Allogeneic Stem Cell Transplantation Patients
Erik Thiele-Orberg, E. Meedt, A. Hiergeist, Jinling Xue +19 more
2023Blood0 citations
Semantic Scholar
Elevated RIPK3 correlates with disease burden in myelofibrosis
V. Dill, Celina V Wagner, Eva C Keller, F. Fernandez-Hernandez +16 more
2022Blood Advances0 citations Open access
Semantic Scholar
Identification of Bacterial and Viral Consortia for the Production of Intestinal Microbiota-Derived Metabolites Associated with Protection in Allogeneic Stem Cell Transplantation Patients
Erik Thiele-Orberg, E. Meedt, A. Hiergeist, Jinling Xue +27 more
2022Blood0 citations Open access
Semantic Scholar
Identification of CXCR4 Expression By Targeted PET/MR Imaging in Patients with Acute Myeloid Leukemia (AML)
P. Herhaus, Stefan Habringer, K. Philipp-Abbrederis, T. Vag +12 more
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Mareike Verbeek×19
Invite
Mareike Verbeek — researcher profile on SciRah
H. Wester×13
Invite
H. Wester — researcher profile on SciRah
U. Keller×12
Invite
U. Keller — researcher profile on SciRah
K. Götze×12
Invite
K. Götze — researcher profile on SciRah

Stefan Habringer

×10

Invite

Stefan Habringer — researcher profile on SciRah

F. Bassermann×10

Invite

F. Bassermann — researcher profile on SciRah

B. von Tresckow×9

Invite

B. von Tresckow — researcher profile on SciRah

Invite

T. Vag — researcher profile on SciRah

M. Schwaiger×8

Invite

M. Schwaiger — researcher profile on SciRah

Invite

C. Lapa — researcher profile on SciRah

P. Bröckelmann×8

Invite

P. Bröckelmann — researcher profile on SciRah

F. Bassermann×8

Invite

F. Bassermann — researcher profile on SciRah